HCW Biologics

HCWBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.303 M

$1.03 -6.36%

Close of 6 Nov 2026

As of 6 Nov 2026, HCW Biologics (HCWB) has a market capitalization of $2.30M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.96M

Loss-making

Shares outstanding

1,836,324

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#478Silo PharmaSILO$2.57M
#479Galmed PharmaceuticalsEOCN$2.55M
#480HCW BiologicsHCWB$2.30M
#481Sunshine BiopharmaSBFM$2.16M
#482Revelation BiosciencesREVB$2.03M

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of HCW Biologics, worth $100.0K. Grants and option exercises are excluded.

Hing C. WongChief Executive Officer$60.0K
23,210 shares at $2.59 on 29 Jul 2026 · filed 31 Jul 2026
Scott T. Garrett$20.0K
7,736 shares at $2.59 on 29 Jul 2026 · filed 31 Jul 2026
Lee FlowersSVP of Business Development$20.0K
7,736 shares at $2.59 on 29 Jul 2026 · filed 31 Jul 2026

What if HCW Biologics were worth as much as…

Open the what-if tool →

Gold $28.2T

$12,626,467

Per share 12,258,705× higher

Bitcoin $1.53T

$683,196.12

Per share 663,297× higher

Apple $5.02T

$2,242,869

Per share 2,177,543× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for HCW Biologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.